Form 4 for IMDX Insight Molecular Diagnostics Inc.
Accepted 2021-07-02 00:00:00 ET · period of report 2021-05-07 · accession 0001493152-21-015984 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-02 | 2021-06-30 | IMDX | ANDREWS RONALD ASBURY | CEO, Dir | F - Tax | $0.00 | -25.9K | 194.0K | -12% | $0 |
| D | 2021-07-02 | 2021-05-07 | IMDX | ANDREWS RONALD ASBURY | CEO, Dir | M - OptEx | $0.00 | +106.2K | 219.9K | +93% | $0 |
| D | 2021-07-02 | 2021-05-07 | IMDX | ANDREWS RONALD ASBURY | CEO, Dir | M - OptEx | $0.00 | -106.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, no par value | 2021-06-30 | F | D | 25,873 | $0.00 | 194,046 | D | — | — | |
| 2 | Common | Common Stock, no par value | 2021-05-07 | M | A | 106,221 | $0.00 | 219,919 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2021-05-07 | M | D | 106,221 | $0.00 | 0 | D | $0.00 · — to — | 106,221 Common Shares | (F2) Restricted Stock Units vested on May 7, 2021. |